Astria Therapeutics Inc. (ATXS)
NASDAQ: ATXS
· Real-Time Price · USD
6.85
0.09 (1.33%)
At close: Aug 15, 2025, 3:59 PM
6.85
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
Astria Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -33.05M | -33.71M | -25.63M | -24.53M | -24.17M | -19.93M | -31.41M | -17.73M | -12.57M | -11.19M | -13.26M | -12M | -11.25M | -15.32M | -9.49M | -7.87M | -7.47M | -170.08M |
Depreciation & Amortization | -1.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 4.35M | 3.84M | 3.4M | 3.43M | 3.45M | 2.75M | 2.07M | 1.69M | 1.33M | 1.22M | 1.07M | 1.16M | 1.12M | 1.21M | 972K | 1.01M | 1.01M | 366K |
Other Working Capital | -3.92M | -2.77M | 2.9M | -3.02M | 4.01M | -757K | -1.44M | 1.31M | 531K | -3.54M | 2.1M | 749.00 | -150 | 719K | 859K | -1.23M | 989K | -1.96M |
Other Non-Cash Items | 1.41M | -1.38M | -1.08M | -2.78M | -1.56M | -512K | 163K | 159K | 107K | 116K | -569K | 48K | 158K | 1.46M | 392K | 390K | 265K | 165.04M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -6.87M | -2.77M | 5.94M | -4.08M | 5.49M | -1.41M | -1.06M | 1.62M | 432K | -3.4M | 2.1M | 545K | -85K | 92K | 1.84M | -1.28M | -199K | -3.67M |
Operating Cash Flow | -36.06M | -34.02M | -17.36M | -27.96M | -16.79M | -19.09M | -30.24M | -14.26M | -10.7M | -13.25M | -10.66M | -10.25M | -10.06M | -12.56M | -6.29M | -7.75M | -7.4M | -8.72M |
Capital Expenditures | -590K | n/a | n/a | -20K | -305K | n/a | -16K | -4K | n/a | -5K | -31K | -58K | -2 | n/a | n/a | n/a | n/a | -21K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 135.15K | n/a | n/a | n/a | -6.47M | n/a | n/a | 6.47M |
Purchase of Investments | -588.42M | -751.42M | -748.72M | -1.06B | -1.39B | -1.05B | -708M | -913.5M | -207M | -95.92M | -178.5M | -52.67M | -83.19M | -81.7M | -78M | n/a | n/a | -6.47M |
Sales Maturities Of Investments | 647M | 780M | 745M | 1.06B | 1.32B | 923M | 706M | 913.5M | 149.08M | 290.92M | 43.35M | 54.68M | 76.39M | 54.6M | 39M | n/a | n/a | 20M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -57.92K | n/a | -135.15K | 2.01K | -6.8K | -27.1K | 6.47M | n/a | n/a | 6.47M |
Investing Cash Flow | 57.99M | 28.58M | -3.72M | 6.19M | -68.1M | -126.23M | -2.02M | -4K | -57.92M | 194.99M | -135.18M | 1.95M | -6.8M | -27.1M | -39M | n/a | n/a | 26.45M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24.44M | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 152.42M | 58K | n/a | 4.63M | n/a | n/a | 273K | 37K | 50K | 34K | n/a | n/a | 17K | 6K | n/a | n/a |
Financial Cash Flow | n/a | n/a | n/a | 15.3M | 94K | 141.81M | 87.98M | 110K | 273K | 37K | 120.4M | 24.32M | n/a | n/a | 17K | 6K | n/a | 104.26M |
Net Cash Flow | 21.93M | -5.43M | -21.08M | -6.48M | -84.8M | -3.52M | 55.72M | -14.15M | -68.34M | 181.78M | -25.45M | 16.02M | -16.86M | -39.66M | -45.27M | -7.74M | -7.4M | 121.99M |
Free Cash Flow | -36.65M | -34.02M | -17.36M | -27.98M | -17.1M | -19.09M | -30.25M | -14.26M | -10.7M | -13.26M | -10.7M | -10.31M | -10.06M | -12.56M | -6.29M | -7.75M | -7.4M | -8.74M |